The Role
Lead Chemistry, Manufacturing, and Controls activities for biologics, develop CMC strategy, manage external partnerships, ensure product consistency, and oversee regulatory support.
Summary Generated by Built In
Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease. Using its proprietary DECODETM platform—which maps the immune synapse between T cell receptors (TCRs) and their antigen targets—Repertoire translates unique biological insights into potent and targeted off-the shelf immune medicines. The company integrates deep protein engineering expertise with artificial intelligence, powered by a proprietary DECODE database of over one billion TCR-antigen interactions, to accelerate discovery and optimize drug candidates.
From its sites in Cambridge, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering with leading pharmaceutical companies to develop mRNA tolerizing therapies designed to selectively expand regulatory T cells and reset the immune system.
Repertoire was founded in 2019 by Flagship Pioneering and is supported by a strong investor base. The DECODE platform has been validated through four strategic partnerships with leading pharmaceutical companies—Bristol Myers Squibb, Genentech, Eli Lilly, and Pfizer—representing over $4.5 billion in disclosed total deal value and $185 million in upfront payments received to date.
Role Overview
Repertoire Immune Medicines is seeking an accomplished and strategic Vice President, Head of CMC to lead all Chemistry, Manufacturing, and Controls activities across the company’s growing pipeline of protein biologics. This senior leader will be responsible for establishing and executing CMC strategy from development candidate nomination through clinical development.
The successful candidate will bring deep expertise in biologics CMC development, demonstrated success building teams and processes in both early‑stage and mature organizations, and a strong track record of technology transfer and management of external manufacturing organizations. This leader will work cross‑functionally with research, preclinical, clinical, regulatory, quality, and finance teams to ensure successful execution of CMC activities related to regulatory filings, cGMP manufacturing and clinical supply.
Key Responsibilities
CMC Strategy and Leadership
Recruitment & Staffing Agencies: Repertoire Immune Medicines (“Repertoire”) does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Repertoire or its employees is strictly prohibited unless contacted directly by Repertoire’s internal Human Resources team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Repertoire, and Repertoire will not owe any referral or other fees with respect thereto.
From its sites in Cambridge, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering with leading pharmaceutical companies to develop mRNA tolerizing therapies designed to selectively expand regulatory T cells and reset the immune system.
Repertoire was founded in 2019 by Flagship Pioneering and is supported by a strong investor base. The DECODE platform has been validated through four strategic partnerships with leading pharmaceutical companies—Bristol Myers Squibb, Genentech, Eli Lilly, and Pfizer—representing over $4.5 billion in disclosed total deal value and $185 million in upfront payments received to date.
Role Overview
Repertoire Immune Medicines is seeking an accomplished and strategic Vice President, Head of CMC to lead all Chemistry, Manufacturing, and Controls activities across the company’s growing pipeline of protein biologics. This senior leader will be responsible for establishing and executing CMC strategy from development candidate nomination through clinical development.
The successful candidate will bring deep expertise in biologics CMC development, demonstrated success building teams and processes in both early‑stage and mature organizations, and a strong track record of technology transfer and management of external manufacturing organizations. This leader will work cross‑functionally with research, preclinical, clinical, regulatory, quality, and finance teams to ensure successful execution of CMC activities related to regulatory filings, cGMP manufacturing and clinical supply.
Key Responsibilities
CMC Strategy and Leadership
- Define and execute end‑to‑end CMC strategy aligned with corporate and clinical development objectives.
- Lead and develop a high‑performing Technical Development Team encompassing upstream, downstream, analytical, and formulation development.
- Serve as the primary CMC leader for development candidate selection and progression decisions.
- Identify, select, and manage CDMOs and CROs; negotiate manufacturing, quality, and supply agreements in partnership with executive leadership and finance.
- Lead seamless technology transfer of manufacturing and analytical processes to external partners for non‑GMP and GMP production.
- Oversee drug substance and drug product manufacturing from development candidate nomination through clinical supply, ensuring on‑time delivery for regulatory submissions and clinical trials.
- Monitor manufacturing timelines, budgets, and performance; proactively identify opportunities to accelerate development and control costs.
- Establish critical quality attributes (CQAs), process controls, and fit‑for‑purpose control strategies to ensure product consistency and robustness.
- Oversee analytical method transfer, method qualification, stability programs, and product shelf‑life assignments.
- Provide leadership and oversight of QA activities with external QA consultants and quality systems appropriate for company stage.
- Oversee clinical labeling, packaging, and supply logistics through supervision of clinical supply partners.
- Review technical documentation and reports from CDMOs and CROs.
- Author and oversee CMC sections of regulatory submissions and amendments.
- Partner closely with Regulatory Affairs to support health authority interactions related to CMC.
- Develop CMC operating plans, milestones, and short‑ and long‑term objectives across all pipeline programs.
- Build scalable systems and processes appropriate for company growth.
- Influence company culture through collaborative leadership, mentorship, and cross‑functional partnership.
- PhD in Biochemistry, Biology, Biotechnology, Chemical Engineering, Biological Engineering, or a related discipline.
- 15+ years of experience in the pharmaceutical or biotechnology industry, with substantial leadership responsibility in biologics CMC, process development, and manufacturing.
- Recognized expert in biologics CMC process, development, and strategy, including application of Quality by Design (QbD) approaches to support robust manufacturing processes and consistent product quality across development stages.
- Proven experience building and leading teams and developing talent in matrixed and outsourced environments.
- Extensive experience with technology transfer to CDMOs, including cell line development, upstream and downstream process development, analytical method development, scale‑up, and GMP manufacturing.
- Hands‑on experience with formulation development and stability studies for drug substance and drug product to support regulatory submissions and clinical trials.
- Strong working knowledge of drug development across research, preclinical, clinical, and regulatory functions.
- Experience with bispecific proteins, Fc‑fusion proteins, or other complex biologics preferred.
- Demonstrated ability to author high‑quality technical documentation for regulatory submissions.
- Exceptional leadership, communication, and stakeholder management skills, with the ability to drive strategic discussions with senior management and external partners.
- Proven ability to build consensus and solve complex problems across diverse, cross‑functional teams.
- Willingness to travel domestically and internationally as needed to support CDMO oversight.
Repertoire is committed towards social responsibility and developing an inclusive culture. Much as the power of the immune system lies in the diversity of T and B cells, our work requires the creativity and ingenuity of a diverse workforce. We believe in actively pursuing equity in all facets of the work experience at Repertoire. We will continue to educate ourselves about the inequities and barriers present in our society and take action as a company where we can make a difference.
Repertoire is proud to be an Equal Opportunity Employer.
Repertoire is proud to be an Equal Opportunity Employer.
Recruitment & Staffing Agencies: Repertoire Immune Medicines (“Repertoire”) does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Repertoire or its employees is strictly prohibited unless contacted directly by Repertoire’s internal Human Resources team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Repertoire, and Repertoire will not owe any referral or other fees with respect thereto.
Am I A Good Fit?
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.
Success! Refresh the page to see how your skills align with this role.
The Company
What We Do
Repertoire Immune Medicines is a biotechnology company dedicated to creating treatments for diseases based on the power of the human T cell repertoire to eliminate cancer cells, target pathogens, and regulate immune function in autoimmune disease. The company’s proprietary DECODE™ platform provides a comprehensive understanding of the interactions between T cell receptors and their antigens in disease. DECODE uniquely elucidates the entire immune synapse, including the T-cell receptor-epitope pairs that defines it, the HLA context, and the T cell phenotype. This capability enables the creation of new and potentially transformative classes of immune-based medicines. Repertoire believes the ability to decipher these interactions represents one of the greatest opportunities for innovation in medical science. The company is utilizing the discoveries from DECODE to design and develop novel immune therapies for multiple therapeutic areas, such as autoimmune diseases, infectious diseases, and cancer. The team operates from sites in Cambridge, Massachusetts and Zurich. To learn more about Repertoire, please visit www.repertoire.com.
